| [1] |
Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, et al. 2021. Global prevalence of diabetic retinopathy and projection of burden through 2045 systematic review and meta-analysis. |
| [2] |
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, et al. 2022. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. |
| [3] |
Cooper OAE, Taylor DJ, Crabb DP, Sim DA, McBain H. 2020. Psychological, social and everyday visual impact of diabetic macular oedema and diabetic retinopathy: a systematic review. |
| [4] |
Scanlon PH. 2021. The contribution of the English NHS Diabetic Eye Screening Programme to reductions in diabetes-related blindness, comparisons within Europe, and future challenges. |
| [5] |
Das T, Takkar B, Sivaprasad S, Thanksphon T, Taylor H, et al. 2021. Recently updated global diabetic retinopathy screening guidelines: commonalities, differences, and future possibilities. |
| [6] |
Teo ZL, Tham YC, Yu M, Cheng CY, Wong TY, et al. 2020. Do we have enough ophthalmologists to manage vision-threatening diabetic retinopathy? A global perspective. |
| [7] |
Wong TY, Sun J, Kawasaki R, Ruamviboonsuk P, Gupta N, et al. 2018. Guidelines on diabetic eye care the international council of ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings. |
| [8] |
Gurudas S, Frudd K, Maheshwari JJ, Revathy YR, Sivaprasad S, et al. 2022. Multicenter evaluation of diagnostic circulating biomarkers to detect sight-threatening diabetic retinopathy. |
| [9] |
Dharmastuti DP, Agni AN, Widyaputri F, Pawiroranu S, Sofro ZM, et al. 2018. Associations of physical activity and sedentary behaviour with vision-threatening diabetic retinopathy in Indonesian population with type 2 diabetes mellitus: Jogjakarta eye diabetic study in the community (JOGED.COM). |
| [10] |
Fenwick EK, Xie J, Man REK, Lim LL, Flood VM, et al. 2015. Moderate consumption of white and fortified wine is associated with reduced odds of diabetic retinopathy. |
| [11] |
Wang L, Liu S, Wang W, He M, Mo Z, et al. 2021. Association between ocular biometrical parameters and diabetic retinopathy in Chinese adults with type 2 diabetes mellitus. |
| [12] |
An Y, Ke J, Zhao D. 2023. 27-LB: a prediction model for diabetic retinopathy based on plasma adipokines among patients with type 2 diabetes. |
| [13] |
Liu Y, Song Y, Tao L, Qiu W, Lv H, et al. 2017. Prevalence of diabetic retinopathy among 13473 patients with diabetes mellitus in China: a cross-sectional epidemiological survey in six provinces. |
| [14] |
Rani PK, Raman R, Sharma V, Mahuli SV, Tarigopala A, et al. 2007. Analysis of a comprehensive diabetic retinopathy screening model for rural and urban diabetics in developing countries. |
| [15] |
Gong D, Fang L, Cai Y, Chong I, Guo J, et al. 2023. Development and evaluation of a risk prediction model for diabetes mellitus type 2 patients with vision-threatening diabetic retinopathy. |
| [16] |
Deng X, Li Z, Zeng P, Wang J, Liang J, et al. 2021. A diagnostic model for screening diabetic retinopathy using the hand-held electroretinogram device RETeval. |
| [17] |
Bearse MA, Adams AJ, Han Y, Schneck ME, Ng J, et al. 2006. A multifocal electroretinogram model predicting the development of diabetic retinopathy. |
| [18] |
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, et al. 2021. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. |
| [19] |
Rostom A, Dubé C, Cranney A, Saloojee N, Sy R, et al. 2004. Celiac disease: summary. AHRQ evidence report summaries No. 104, Agency for Healthcare Research and Quality (AHRQ), Rockville, MD, USA www.ncbi.nlm.nih.gov/books/NBK35156/ |
| [20] |
American Diabetes Association. 2016. Classification and diagnosis of diabetes. |
| [21] |
Levey AS, Cattran D, Friedman A, Miller WG, Sedor J, et al. 2009. Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the national kidney foundation and the US food and drug administration. |
| [22] |
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, et al. 2009. A new equation to estimate glomerular filtration rate. |
| [23] |
Cheung N, Mitchell P, Wong TY. 2010. Diabetic retinopathy. |
| [24] |
Hosmer DW Jr, Lemeshow S, Sturdivant RX. 2013. Applied Logistic Regression. Hoboken, New Jersey, USA: John Wiley & Sons. doi: 10.1002/9781118548387 |
| [25] |
Hu Y, Chan Z, Li C, Shi Y, She X, et al. 2021. Higher serum uric acid levels are associated with an increased risk of vision-threatening diabetic retinopathy in type 2 diabetes patients. |
| [26] |
Liu Y, Yang J, Tao L, Lv H, Jiang X, et al. 2017. Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: a cross-sectional study of 13473 patients with type 2 diabetes mellitus in mainland China. |
| [27] |
Nakamura M, Barber AJ, Antonetti DA, LaNoue KF, Robinson KA, et al. 2001. Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons. |
| [28] |
Knudsen LL, Lervang HH, Lundbye-Christensen S, Gorst-Rasmussen A. 2006. The north Jutland County diabetic retinopathy study: population characteristics. |
| [29] |
Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, et al. 2010. Prevalence of diabetic retinopathy in the United States, 2005−2008. |
| [30] |
Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, et al. 2010. Effects of medical therapies on retinopathy progression in type 2 diabetes. |
| [31] |
Hu Y, Zhou C, Shi Y, She X, Zhao S, et al. 2021. A higher serum calcium level is an independent risk factor for vision-threatening diabetic retinopathy in patients with type 2 diabetes: cross-sectional and longitudinal analyses. |
| [32] |
Li YY, Yang XF, Gu H, Liu XP, Snellingen T, et al. 2018. The Beijing Desheng Diabetic Eye Study: rationale, design, methodology and baseline data. |
| [33] |
Wu G, Hu Y, Zhu Q, Liang A, Du Z, et al. 2024. Development and validation of a simple and practical model for early detection of diabetic macular edema in patients with type 2 diabetes mellitus using easily accessible systemic variables. |
| [34] |
Pawlak K, Mysliwiec M, Pawlak D. 2008. Oxidative stress, phosphate and creatinine levels are independently associated with vascular endothelial growth factor levels in patients with chronic renal failure. |
| [35] |
Ziyadeh F, Wolf G. 2008. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. |
| [36] |
Daruich A, Matet A, Moulin A, Kowalczuk L, Nicolas M, et al. 2018. Mechanisms of macular edema: beyond the surface. |
| [37] |
Nithyanandam S, Ajoy Mohan VK, Idiculla J. 2011. Microalbuminuria and low hemoglobin as risk factors for the occurrence and increasing severity of diabetic retinopathy. |
| [38] |
Noma H, Yasuda K, Shimura M. 2021. Involvement of cytokines in the pathogenesis of diabetic macular edema. |
| [39] |
Ma R, Zheng C, Niu Y, et al. 2026. Changes of retinal microvascular parameters in patients with type 2 diabetes mellitus with or without diabetic kidney disease. |
| [40] |
Zheng C, Cao D, Ma R, Hao X, Jin L, et al. 2026. Current status of multi-target therapeutics for diabetic macular oedema: mechanisms and outcomes from clinical trials. |
| [41] |
Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, et al. 1998. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Investigative Ophthalmology & Visual Science 39:233−252 |
| [42] |
Traveset A, Rubinat E, Ortega E, Alcubierre N, Vazquez B, et al. 2016. Lower hemoglobin concentration is associated with retinal ischemia and the severity of diabetic retinopathy in type 2 diabetes. |